VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
OCGN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
OCGNOcugen, Inc.
$0.93$314M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksOCGNBalance Sheet

Ocugen, Inc. (OCGN) Balance Sheet

14Y historyFree accessUpdated daily

Total debt surged to $86.3M in 2026Q2 from $33.3M one quarter prior while equity flipped to -$16.6M and the current ratio fell to 0.80, rendering debt-to-equity uncomputable and suggesting a materially more constraining capital structure despite $100.1M of cash.

Income StatementBalance SheetCash FlowRatios

OCGN Balance Sheet

Annual statement

OCGN Balance Sheet

Ocugen, Inc. (OCGN) balance sheet — 14-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Total Current Assets91.43M24.34M61.68M42.97M98.49M102.65M25.88M15.77M16.4M8.18M32.08M31.24M58.86M10.35M15.08M
Cash & Short-Term Investments84.26M18.57M58.51M39.46M90.93M94.96M24.04M7.44M15.54M7.98M31.91M30.91M58.06M8.73M14.72M
Cash Only24.63M18.57M58.51M39.46M77.56M94.96M24.04M7.44M15.54M7.08M31.91M30.91M58.06M8.73M14.72M
Short-Term Investments59.63M00013.37M0000900K00000
Accounts Receivable000000000000000
Days Sales Outstanding---------------
Inventory000000000000000
Days Inventory Outstanding---------------
Other Current Assets05.77M3.17M3.51M7.56M007M172K122K78K279K729K1.13M340K
Total Non-Current Assets16.63M19.18M20.76M21.58M10.14M3.12M1.5M1.04M1.03M2.86M4M5.55M6.64M4.45M5.96M
Property, Plant & Equipment12.71M14.39M16.55M17.29M6.05M1.16M633K222.46K141K2.72M3.86M5.21M4.88M2.28M2.31M
Fixed Asset Turnover0.35x0.31x0.24x0.35x0.41x-0.07x------0.00x0.01x
Goodwill000000000000000
Intangible Assets00000000000200K510K570K630K
Long-Term Investments954K000000151.02K150.48K137K00000
Other Non-Current Assets3.92M4.78M4.21M4.29M4.09M1.95M865K667.75K736.52K0137K137K604K539K540K
Total Assets108.06M43.52M82.44M64.55M108.63M105.76M27.38M16.81M17.43M11.04M36.08M36.79M65.5M14.8M21.04M
Asset Turnover0.06x0.10x0.05x0.09x0.02x-0.00x------0.00x0.00x
Asset Growth %161.37%-47.22%27.72%-40.58%2.71%286.33%62.88%-3.56%57.93%-69.41%-1.92%-43.84%342.68%-29.69%-
Total Current Liabilities118.9M23.04M21.59M17.09M28.53M7M3.61M4.54M2.87M3.81M5.17M6.36M8.25M5.09M4.4M
Accounts Payable5.07M6.2M4.24M3.17M8.06M2.31M395K1.9M1.59M776K1.95M2.25M4.89M2.53M1.04M
Days Payables Outstanding3.27K947.56786.941.64K--22.6985.5711.7K184.64425509.51---
Short-Term Debt83.15M1.25M1.33M000234K00178K583K583K405K00
Deferred Revenue (Current)17.71M5.91M8.37M10.53M11.22M002.27M10M2.02M2.13M2.98M2.83M00
Other Current Liabilities22.26M6.69M5.25M1.03M3.11M1.72M1.68M-2.06M948K1.18M1.24M2.77M2.22M1.69M1.14M
Current Ratio0.77x1.06x2.86x2.51x3.45x14.66x7.16x3.47x5.71x2.15x6.20x4.91x7.13x2.03x3.42x
Quick Ratio0.77x1.06x2.86x2.51x3.45x14.66x7.16x3.47x5.71x2.15x6.20x4.91x7.13x2.03x3.42x
Cash Conversion Cycle---------------
Total Non-Current Liabilities6.84M32.64M31.22M6.89M6.12M2.94M2.21M1.25M15.01M18.5M17.34M2.23M3.04M85.26M36.35M
Long-Term Debt1.74M27.54M27.34M2.8M2.29M1.71M1.82M1.07M1.02M0178K761K1.34M00
Capital Lease Obligations12.61M3.49M3.31M3.57M3.59M1.23M389K163.2K0000000
Deferred Tax Liabilities773K00918K0000-1.02M000651K00
Other Non-Current Liabilities2.28M1.6M564K527K244K009.76K4M18.5M17.16M1.47M1.05M85.26M36.35M
Total Liabilities125.74M55.68M52.81M23.98M34.65M9.94M5.83M5.79M17.89M22.3M22.51M8.59M11.29M90.35M40.76M
Total Debt88.56M33.14M32.5M6.94M6.37M3.31M2.49M1.41M238K178K761K1.34M1.75M00
Net Debt63.93M14.57M-26.01M-32.52M-71.19M-91.65M-21.55M-6.04M-15.3M-6.9M-31.15M-29.57M-56.31M-8.73M-14.72M
Debt / Equity-5.01x-1.10x0.17x0.09x0.03x0.12x0.13x--0.06x0.05x0.03x--
Debt / EBITDA-1.33x--------------
Net Debt / EBITDA-0.96x--------------
Interest Coverage-7.03x-12.08x----738.46x-19.81x-8.01x-88.77x-197.12x-217.47x-239.78x-149.95x--18.76x
Total Equity-17.68M-12.17M29.63M40.56M73.98M95.82M21.55M11.02M-458K-11.27M13.57M28.2M54.21M-75.55M-19.71M
Equity Growth %-1447.5%-141.06%-26.95%-45.17%-22.79%344.63%95.58%2505.77%95.94%-183.05%-51.89%-47.98%171.74%-283.31%-
Book Value per Share-0.05-0.040.110.170.340.490.190.79-0.74-29.8256.57127.872120.07-355.35-92.71
Total Shareholders' Equity-17.68M-12.17M29.63M40.56M73.98M95.82M21.55M11.02M-458K-11.27M13.57M28.2M54.21M-75.55M-19.71M
Common Stock3.39M3.13M2.92M2.57M2.22M2M1.84M527.47K513K159K159K132K127K6K6K
Retained Earnings-455.72M-408.07M-340.22M-286.17M-223.09M-131.67M-73.3M-51.48M-216.83M-208.19M-181.77M-165.56M-133.54M-110.75M-85.04M
Treasury Stock-48K-48K-48K-48K-48K-48K-48K-47.86K0000000
Accumulated OCI146K61K48K20K26K000-10.29M-10.92M-9.39M-7.99M-6.38M-5.65M-5.15M
Minority Interest000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetMixed
Cash FlowMixed
Top Statement Risk

Negative equity amid rising leverage

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Asset Growth Masks Equity Erosion

Ocugen's total assets climbed to $124.2M in 2026Q2 from $51.8M in early 2024 according to its quarterly balance sheets, yet equity flipped to -$16.6M as liabilities exceeded assets, suggesting balance sheet expansion driven by leverage rather than retained value creation.

The balance sheet's size has more than doubled over ten quarters, yet the expansion appears concentrated in a single quarter — total debt rose from $33.3M to $86.3M between 2026Q1 and 2026Q2 while equity fell from $5.8M to -$16.6M. With accumulated losses deepening to -$452.1M and book value now negative, this pattern suggests the company's financial structure has shifted materially toward creditor claims, which may constrain strategic flexibility and refinancing options.

Debt Surge Reshapes Capital Structure

Total debt rose sharply to $86.3M in 2026Q2 from $33.3M in the prior quarter, as disclosed in Ocugen's filings, while negative equity of -$16.6M renders the debt-to-equity ratio uncomputable — a shift suggesting leverage has moved from moderate to potentially constraining.

Debt had been stable near $33M for five consecutive quarters before the 2026Q2 spike, implying a discrete financing event rather than gradual accumulation. At $86.3M, debt now represents roughly 69% of total assets — a sharp concentration of creditor claims on a balance sheet that simultaneously shows negative book equity. Investors should monitor whether servicing costs associated with this step-change in borrowing will compound the operating losses already evident in recent income statements.

Cash Strength Contradicts Sub-1.0 Ratio

Ocugen's current ratio fell to 0.80 in 2026Q2 — the first sub-1.0 reading in ten quarters — while cash climbed to $100.1M, based on reported balance sheets, suggesting short-term obligations may now outpace liquid assets despite a substantial cash balance.

The juxtaposition of a record-high cash position against a deteriorating current ratio implies that non-cash current liabilities have expanded materially alongside the debt raise rather than being extinguished by the inflow. The ratio had historically ranged between 1.04 and 2.86, so the drop to 0.80 marks a structural break that may indicate reclassification of debt into current maturities or a surge in accrued obligations. With $100.1M of cash against $140.8M of total liabilities, the theoretical buffer exists, but its availability for near-term claims depends on the composition of those obligations, which warrants further investigation.

Book Value Exhausted by Cumulative Losses

Ocugen's equity deteriorated from $30.3M in 2024Q1 to -$16.6M in 2026Q2, driven by accumulated retained losses of -$452.1M, as reported in its financial statements — indicating cumulative losses and recent leverage have fully eroded the shareholders' book value position.

The equity line has been volatile — swinging from $40.6M in 2024Q3 to $3.1M a year later — but the trajectory is unambiguously downward, with retained losses widening by roughly $12M to $25M per quarter across the window. Negative book value means the company's assets are now entirely claims of creditors and other liabilities, a condition that typically raises the cost of future equity issuance. Given that the income statement already shows deepening losses without a corresponding revenue inflection, the equity erosion appears structural rather than a timing artifact.

Cash Inflow May Be Debt-Encumbered

Ocugen's cash jumped from $31.9M to $100.1M in a single quarter alongside a $53.0M debt increase, per its balance sheets — yet the current ratio simultaneously fell to 0.80, suggesting the new liquidity may already be encumbered by near-term obligations warranting investigation.

A casual reading might celebrate the roughly $68M cash build as balance sheet strengthening, but the concurrent deterioration of equity and current ratio suggests the inflow arrived alongside offsetting obligations rather than representing free cash generation. Deferred revenue also fell to $0 in 2026Q2 from $5.2M the prior quarter, eliminating what had been a modest non-debt source of working capital. The combination of a debt-funded cash pile, vanishing deferred revenue, and negative book equity points to a liquidity position that may be more fragile than the headline cash figure implies.

OCGN — Frequently Asked Questions

Quick answers to the most common questions about buying OCGN stock.

What are the total assets of Ocugen, Inc. (OCGN)?

As of 2025, Ocugen, Inc. (OCGN) had total assets of $43.5M including $24.3M in current assets.

How much debt does Ocugen, Inc. (OCGN) have?

Ocugen, Inc. (OCGN) carries total debt of $33.1M, offset by $18.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Ocugen, Inc.?

Ocugen, Inc. (OCGN) has total shareholders' equity (book value) of $-12.2M ($-0.04 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Ocugen, Inc.'s current ratio and liquidity?

Ocugen, Inc. (OCGN) reported a current ratio of 1.06x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.